vancomycin has been researched along with nvp pdf 713 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amaral, K; Dzink-Fox, J; Fischer, E; Goldovitz, J; Manni, K; Neckermann, G; Osborne, CS; Pecanka, R; Ryder, NS; Yu, D | 1 |
Duan, Y; Hu, W; Li, M; Qian, Y; Shi, W; Yang, L | 1 |
Aubart, K; Duan, Y; Fang, Y; Hu, W; Ma, H; Shi, W; Yang, L; Zonis, R | 1 |
3 other study(ies) available for vancomycin and nvp pdf 713
Article | Year |
---|---|
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
Topics: Acetamides; Amidohydrolases; Animals; Anti-Infective Agents; Female; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Peptides; Pneumonia; Staphylococcus aureus; Streptococcus pneumoniae; Thigh | 2009 |
Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Topics: Amidohydrolases; Amines; Anti-Bacterial Agents; Drug Design; Pyrroles; Structure-Activity Relationship | 2010 |
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Topics: Amidohydrolases; Anti-Bacterial Agents; Drug Design; Drug Resistance, Bacterial; Enzyme Inhibitors; Haemophilus influenzae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrrolidines | 2011 |